Skip to content

Effects of Baduanjin exercise on cancer-related fatigue in patients with prostate cancer treated with androgen deprivation therapy: study protocol for a randomized controlled trial

Effects of Baduanjin exercise on cancer-related fatigue in patients with prostate cancer treated with androgen deprivation therapy: study protocol for a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074293
Enrollment
Unknown
Registered
2023-08-03
Start date
2023-08-10
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer-related fatigue

Interventions

Sponsors

Shanghai Hudong hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1)clinical diagnosis of PCa and treated with ADT for =3 months; (2)Piper Fatigue Self-Assessment Scale (PFS) score =4 (Moderate to severe Fatigue); (3)can communicate and write normally; (4)aged between 18~70 years; (5)voluntary participation, have understood and signed the written informed consent form.

Exclusion criteria

Exclusion criteria: (1)have serious damage of heart, liver, kidney and other important organs; (2)have any diseases affecting motor nerves, muscles and joints; (3)unable to perform Baduanjin exercise due to physical conditions or other reasons; (4)suffered from other neoplastic diseases; (5)have mental illness or severe cognitive impairment or language barrier; (6)participating in other clinical exercise, or regularly exercise more than 3 times a week; (7)expectation of life less than 1 year; (8)for other reasons, the researcher do not consider them suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Piper Fatigue Self-Assessment Scale (PFS);

Secondary

MeasureTime frame
Brief Fatigue Inventory (BFI);Pittsburgh Sleep Quality Index (PSQI);Beck Depression Inventory (BDI);Functional Assessment of Cancer Therapy-Prostate(FACT-P);

Countries

China

Contacts

Public ContactQin Yuan

Shanghai University of Traditional Chinese Medicine

qinyuan@shutcm.edu.cn+86 150 2133 7413

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026